Surmodics reports Q2 EPS (13c), consensus (11c)

Reports Q2 revenue $28.09M, consensus $32.23M. “In second quarter of fiscal 2025, our total revenue performance on a year-over-year basis was challenged by $3.3 million of lower revenue related to our SurVeil DCB, and by $1.4 million of performance coating royalty and license fee catch-up payments received from our customers in the prior year period,” said Gary Maharaj, President and CEO of Surmodics (SRDX), Inc. “While we are disappointed by their impact on our performance, these two headwinds were anticipated and the rest of our business remained stable on an underlying basis, generating modest revenue growth year-over-year.”